Cortical Labs

Executive Summary

Cortical Labs is a Singapore-based biotech pioneering the integration of biological neural networks with silicon chips to create bio-computing systems. By culturing brain cells on microelectrode arrays, the company aims to perform computational tasks, advancing neuroscience research and offering a new paradigm for artificial intelligence. Founded in 2019, the company is in the platform stage with fewer than 50 employees and has not disclosed total funding or valuation. Its innovative approach has potential applications in drug discovery, neuromorphic computing, and understanding neural computation. However, the technology is at an early stage and faces significant scientific and engineering challenges, including scalability, reproducibility, and ethical considerations. The executive summary highlights the company's unique value proposition while acknowledging the nascent state of its technology and the need for further validation and funding.

Upcoming Catalysts (preview)

• Q4 2026Publication of proof-of-concept results in peer-reviewed journal70% success
• Q2 2027Strategic partnership with pharmaceutical or tech company40% success
• Q3 2027Series A funding round exceeding $10M50% success